ArticleMolecular cancer therapeutics2025

KT-253, a Novel MDM2 Degrader and p53 Stabilizer, Has Superior Potency and Efficacy than MDM2 Small-Molecule Inhibitors.

Yogesh K Chutake et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.